Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design. - Fujiki, Shinya; Iijima, Kenichi; Okabe, Masaaki; Niwano, Shinichi; Tsujita, Kenichi; Naito, Shigeto; Ando, Kenji; Kusano, Kengo; Kato, Ritsushi; Nitta, Junichi; Miura, Tetsuji; Mitsuhashi, Takeshi; et al. (Diabetes Therapy, 2020)